Huang et al. have studied the association of CD318 with the cervical cancer immune microenvironment and stated that CD318 modulates the immune microenvironment of cervical cancer through the inhibition of the JAK-STAT pathway in T cells by binding to CD6 [44]. This evidence concerns the gene CDCP1 and cervical cancer.